255 related articles for article (PubMed ID: 25622129)
1. Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches.
Nguyen PT; Yu H; Keller PA
J Mol Graph Model; 2015 Apr; 57():1-8. PubMed ID: 25622129
[TBL] [Abstract][Full Text] [Related]
2. Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease.
Dhindwal S; Kesari P; Singh H; Kumar P; Tomar S
J Biomol Struct Dyn; 2017 Dec; 35(16):3522-3539. PubMed ID: 27844505
[TBL] [Abstract][Full Text] [Related]
3. Design and Validation of Novel Chikungunya Virus Protease Inhibitors.
Das PK; Puusepp L; Varghese FS; Utt A; Ahola T; Kananovich DG; Lopp M; Merits A; Karelson M
Antimicrob Agents Chemother; 2016 Dec; 60(12):7382-7395. PubMed ID: 27736770
[TBL] [Abstract][Full Text] [Related]
4. Structure-function relationship of Chikungunya nsP2 protease: A comparative study with papain.
Ramakrishnan C; Kutumbarao NHV; Suhitha S; Velmurugan D
Chem Biol Drug Des; 2017 May; 89(5):772-782. PubMed ID: 28054451
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site.
Narwal M; Singh H; Pratap S; Malik A; Kuhn RJ; Kumar P; Tomar S
Int J Biol Macromol; 2018 Sep; 116():451-462. PubMed ID: 29730006
[TBL] [Abstract][Full Text] [Related]
6. Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus.
Nguyen PT; Yu H; Keller PA
J Mol Model; 2014 May; 20(5):2216. PubMed ID: 24756552
[TBL] [Abstract][Full Text] [Related]
7. Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease.
Singh KhD; Kirubakaran P; Nagarajan S; Sakkiah S; Muthusamy K; Velmurgan D; Jeyakanthan J
J Mol Model; 2012 Jan; 18(1):39-51. PubMed ID: 21445710
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors.
El-labbad EM; Ismail MA; Abou Ei Ella DA; Ahmed M; Wang F; Barakat KH; Abouzid KA
Chem Biol Drug Des; 2015 Dec; 86(6):1518-27. PubMed ID: 26212366
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
[TBL] [Abstract][Full Text] [Related]
12. Interdomain Flexibility of Chikungunya Virus nsP2 Helicase-Protease Differentially Influences Viral RNA Replication and Infectivity.
Law YS; Wang S; Tan YB; Shih O; Utt A; Goh WY; Lian BJ; Chen MW; Jeng US; Merits A; Luo D
J Virol; 2021 Feb; 95(6):. PubMed ID: 33328310
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidone derivatives as inhibitors of chikungunya virus.
Jadav SS; Sinha BN; Hilgenfeld R; Pastorino B; de Lamballerie X; Jayaprakash V
Eur J Med Chem; 2015 Jan; 89():172-8. PubMed ID: 25462237
[TBL] [Abstract][Full Text] [Related]
14. Promising inhibitors of nsp2 of CHIKV using molecular docking and temperature-dependent molecular dynamics simulations.
Meena MK; Kumar D; Kumari K; Kaushik NK; Kumar RV; Bahadur I; Vodwal L; Singh P
J Biomol Struct Dyn; 2022 Aug; 40(13):5827-5835. PubMed ID: 33472563
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the inhibition of the nsP2 protease from Chikungunya virus by molecular modeling approaches.
Rabelo VW; de Palmer Paixão ICN; Abreu PA
J Mol Model; 2022 Sep; 28(10):311. PubMed ID: 36097090
[TBL] [Abstract][Full Text] [Related]
16. Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity.
Kumar S; Kumar A; Mamidi P; Tiwari A; Kumar S; Mayavannan A; Mudulli S; Singh AK; Subudhi BB; Chattopadhyay S
Sci Rep; 2018 Jan; 8(1):1045. PubMed ID: 29348627
[TBL] [Abstract][Full Text] [Related]
17. Molecular Docking Studies to Explore Potential Binding Pockets and Inhibitors for Chikungunya Virus Envelope Glycoproteins.
Nguyen PTV; Yu H; Keller PA
Interdiscip Sci; 2018 Sep; 10(3):515-524. PubMed ID: 28283929
[TBL] [Abstract][Full Text] [Related]
18. A phenotypic assay to identify Chikungunya virus inhibitors targeting the nonstructural protein nsP2.
Lucas-Hourani M; Lupan A; Desprès P; Thoret S; Pamlard O; Dubois J; Guillou C; Tangy F; Vidalain PO; Munier-Lehmann H
J Biomol Screen; 2013 Feb; 18(2):172-9. PubMed ID: 22983165
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
[TBL] [Abstract][Full Text] [Related]
20. Identification of non-macrocyclic small molecule inhibitors against the NS3/4A serine protease of hepatitis C virus through in silico screening.
Chaudhuri R; Lee H; Truong L; Torres J; Patel K; Johnson ME
J Chem Inf Model; 2012 Aug; 52(8):2245-56. PubMed ID: 22697413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
